1. Home
  2. Labeler Index
  3. Apotheca Inc.
  4. NDC Product Code: 12634-530 Diethylpropion Hydrochloride

NDC 12634-530 Diethylpropion Hydrochloride

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 12634-530?
  5. Diethylpropion Hydrochloride Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Patient Education

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
12634-530
Proprietary Name:
Diethylpropion Hydrochloride
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Apotheca Inc.
Labeler Code:
12634
Product Label ID:
0971fa2e-d660-48b0-9fbb-96a2db167b92
Start Marketing Date: [9]
08-06-1959
Listing Expiration Date: [11]
12-31-2022
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
Shape:
ROUND (C48348)
Size(s):
10 MM
Imprint(s):
WATSON;783
Score:
1

Code Structure Chart

Product Details

What is NDC 12634-530?

The NDC code 12634-530 is assigned by the FDA to the product Diethylpropion Hydrochloride which is product labeled by Apotheca Inc.. The product's dosage form is . The product is distributed in 38 packages with assigned NDC codes 12634-530-00 10 tablet in 1 bottle , 12634-530-01 100 tablet in 1 bottle , 12634-530-09 35 tablet in 1 bottle , 12634-530-12 120 tablet in 1 bottle , 12634-530-18 180 tablet in 1 bottle , 12634-530-40 40 tablet in 1 bottle , 12634-530-42 42 tablet in 1 bottle , 12634-530-45 45 tablet in 1 bottle , 12634-530-50 50 tablet in 1 bottle , 12634-530-52 12 tablet in 1 blister pack , 12634-530-54 14 tablet in 1 blister pack , 12634-530-57 20 tablet in 1 blister pack , 12634-530-59 30 tablet in 1 blister pack , 12634-530-60 60 tablet in 1 bottle , 12634-530-61 10 tablet in 1 blister pack , 12634-530-63 3 tablet in 1 blister pack , 12634-530-66 6 tablet in 1 blister pack , 12634-530-67 7 tablet in 1 blister pack , 12634-530-69 9 tablet in 1 blister pack , 12634-530-71 30 tablet in 1 bottle , 12634-530-74 24 tablet in 1 bottle , 12634-530-78 28 tablet in 1 bottle , 12634-530-79 25 tablet in 1 bottle , 12634-530-80 20 tablet in 1 bottle , 12634-530-81 21 tablet in 1 bottle , 12634-530-82 12 tablet in 1 bottle , 12634-530-84 14 tablet in 1 bottle , 12634-530-85 15 tablet in 1 bottle , 12634-530-90 90 tablet in 1 bottle , 12634-530-91 1 tablet in 1 blister pack , 12634-530-92 2 tablet in 1 bottle , 12634-530-93 3 tablet in 1 bottle , 12634-530-94 4 tablet in 1 bottle , 12634-530-95 5 tablet in 1 bottle , 12634-530-96 6 tablet in 1 bottle , 12634-530-97 7 tablet in 1 bottle , 12634-530-98 8 tablet in 1 bottle , 12634-530-99 9 tablet in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Diethylpropion Hydrochloride?

Diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of BMI based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. Body Mass Index (BMI), kg/m 2 Weight (pounds) Height (feet, inches)  5’0” 5’3” 5’6” 5’9” 6’0” 6’3” 140 27 25 23 21 19 18 150 29 27 24 22 20 19 160 31 28 26 24 22 20 170 33 30 28 25 23 21 180 35 32 29 27 25 23 190 37 34 31 28 26 24 200 39 36 32 30 27 25 210 41 37 34 31 29 26 220 43 39 36 33 30 28 230 45 41 37 34 31 29 240 47 43 39 36 33 30 250 49 44 40 37 34 31The usefulness of agents of this class (see CLINICAL PHARMACOLOGY) should be measured against possible risk factors inherent in their use such as those described below. Diethylpropion hydrochloride is indicated for use as monotherapy only.

Which are Diethylpropion Hydrochloride UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Diethylpropion Hydrochloride Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Diethylpropion Hydrochloride?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Patient Education

Diethylpropion


Diethylpropion decreases appetite. It is used on a short-term basis (a few weeks), in combination with diet, to help you lose weight. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".